Abstract
This review article examines the vital role of selenium, an essential trace element, in the management of Human Immunodeficiency Virus (HIV). Selenium’s intrinsic role in human health is emphasized due to its involvement in the synthesis of selenoproteins, critical for antioxidant defense mechanisms, where it mitigates cellular damage and inflammation. A particular focus is given to how selenium levels, often found to be deficient in individuals with HIV, correlate with the progression and management of the disease. The deficiency has been associated with advanced disease states, heightened risk of mortality, and increased susceptibility to opportunistic infections. Correcting selenium levels emerges as a crucial strategy, complementing antiretroviral therapy (ART), not only controlling viral replication but also improving overall well-being in affected individuals. The broader implications of selenium include its role in reducing the risk of co-infections, drug resistance, cardiovascular complications, and other conditions associated with HIV. This article endeavors to explain the multifaceted benefits of selenium in HIV management, exploring its potential to improve the quality of life for those living with HIV and reflecting on its significance in evolving comprehensive HIV care strategies.

This publication has 19 references indexed in Scilit: